499 related articles for article (PubMed ID: 27385363)
21. Risk Factors of Thyroid Eye Disease.
Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
[TBL] [Abstract][Full Text] [Related]
22. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
Poon SHL; Cheung JJ; Shih KC; Chan YK
Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
[TBL] [Abstract][Full Text] [Related]
23. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
Mourits MP
Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
[No Abstract] [Full Text] [Related]
24. Graves' disease: clinical pathophysiology, presentation and treatment options.
Holt K
J Pract Nurs; 2010; 60(3):13-8. PubMed ID: 21175104
[No Abstract] [Full Text] [Related]
25. [Graves' orbitopathy: diagnosis, epidemiology and treatments].
Lun AY; Le Bras M; Scharbarg E; Morcel P; Hadjadj S; Lebranchu P; Drui D
Rev Med Interne; 2022 Apr; 43(4):242-251. PubMed ID: 35221112
[TBL] [Abstract][Full Text] [Related]
26. [Thyroid ophthalmopathy at the time of European Group On Graves Orbitopathy (EUGOGO)].
Sadoul JL
Presse Med; 2011 Dec; 40(12 Pt 1):1163-73. PubMed ID: 22119334
[TBL] [Abstract][Full Text] [Related]
27. Thyroid-associated ophthalmopathy in Iranian patients.
Kashkouli MB; Jam S; Sabzvari D; Ketabi N; Azarinia S; SeyedAlinaghi S; Mofid A
Acta Med Iran; 2011; 49(9):612-8. PubMed ID: 22052145
[TBL] [Abstract][Full Text] [Related]
28. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
29. Hypo vs. hyperthyroid eye disease: is there any difference?
Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
BMC Ophthalmol; 2023 Feb; 23(1):58. PubMed ID: 36765316
[TBL] [Abstract][Full Text] [Related]
30. Coincidental Optic Nerve Meningioma and Thyroid Eye Disease.
Garg A; Patel P; Lignelli A; Baron E; Kazim M
Ophthalmic Plast Reconstr Surg; 2015; 31(4):e94-5. PubMed ID: 24833445
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review.
Luccas R; Riguetto CM; Alves M; Zantut-Wittmann DE; Reis F
Front Endocrinol (Lausanne); 2023; 14():1277961. PubMed ID: 38260158
[TBL] [Abstract][Full Text] [Related]
32. Alemtuzumab-Induced Thyroid Eye Disease: A Comprehensive Case Series and Review of the Literature.
Nirmalan A; Blecher N; Hyder S; Couch SM; Godfrey KJ; Stan MN; Bradley EA; Wagner LH; Tooley AA
Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):470-474. PubMed ID: 36893061
[TBL] [Abstract][Full Text] [Related]
33. [Monoclonal antibodies in the treatment of thyroid eye disease].
Cheredanova VR; Poteshkin YE
Vestn Oftalmol; 2021; 137(4):116-122. PubMed ID: 34410066
[TBL] [Abstract][Full Text] [Related]
34. Update on the surgical management of Graves' orbitopathy.
Baeg J; Choi HS; Kim C; Kim H; Jang SY
Front Endocrinol (Lausanne); 2022; 13():1080204. PubMed ID: 36824601
[TBL] [Abstract][Full Text] [Related]
35. Graves' ophthalmopathy.
Yeatts RP
Med Clin North Am; 1995 Jan; 79(1):195-209. PubMed ID: 7808092
[TBL] [Abstract][Full Text] [Related]
36. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
37. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy.
Antonelli A; Fallahi P; Elia G; Ragusa F; Paparo SR; Ruffilli I; Patrizio A; Gonnella D; Giusti C; Virili C; Centanni M; Shoenfeld Y; Ferrari SM
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101388. PubMed ID: 32059832
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of Graves' hyperthyroidism and Graves' orbitopathy after fine-needle aspiration biopsy of thyroid nodules.
Lanzolla G; Marcocci C; Marinò M
J Endocrinol Invest; 2020 Jul; 43(7):1033-1034. PubMed ID: 32077044
[No Abstract] [Full Text] [Related]
39. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
40. No light perception vision from compressive thyroid orbitopathy.
Hornbeak DM; Tamhankar MA; Eckstein LA
Orbit; 2014 Feb; 33(1):72-4. PubMed ID: 24206015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
